Skip to main content
logo
Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.34
-0.01 (-0.11%)
May 5, 2026, 12:51 PM EDT - Market open

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 87.27B INR in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 345.83B, up 11.09% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
345.83B INR
Revenue Growth
+11.09%
P/S Ratio
2.89
Revenue / Employee
12,435,044 INR
Employees
27,811
Market Cap
11.13B USD

Revenue Chart

* This company reports financials in INR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Viatris14.30B
Elanco Animal Health4.72B
United Therapeutics3.18B
Amneal Pharmaceuticals3.02B
Neurocrine Biosciences2.86B
Hims & Hers Health2.35B
Lantheus Holdings1.54B
Alkermes1.48B
Revenue Rankings

RDY News

More News